Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ZDLD20 is an orally active and selective CDK4 inhibitor, a β-carboline analog with anti-HCT116 and anticancer activity that inhibits colony formation, inhibits invasion and migration, induces apoptosis, and prevents the G1 phase of the cell cycle.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 48.00 | |
5 mg | In stock | $ 113.00 | |
10 mg | In stock | $ 185.00 | |
25 mg | In stock | $ 372.00 | |
50 mg | In stock | $ 596.00 | |
100 mg | In stock | $ 953.00 | |
500 mg | In stock | $ 1,880.00 |
Description | ZDLD20 is an orally active and selective CDK4 inhibitor, a β-carboline analog with anti-HCT116 and anticancer activity that inhibits colony formation, inhibits invasion and migration, induces apoptosis, and prevents the G1 phase of the cell cycle. |
Molecular Weight | 386.45 |
Formula | C22H22N6O |
CAS No. | 2762279-02-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 15 mg/mL (38.81 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ZDLD20 2762279-02-5 Apoptosis inhibitor inhibit